MYC and neuroblastoma: Over-lapping analysis with ChIP-seq datasets in ChIPBase 3.0 32 revealed that 1998 up-regulated and 1478 down-regulated genes were MYC downstream targets, while 96 and 54 of them were consistently associated with unfavorable or favorable outcome of 498 (GSE62564), 649 (GSE45547), 283(GSE85047), 122 (Versteeg), and 88 (GSE16476) NB patients, respectively (Figure 2A and Table S5).